Advanced Nanotherapies Inc. — Form D
Advanced Nanotherapies Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-22. The offering totals $9.2M, of which $9.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-08-22
- Form: D
- Accession: 0001940022-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.2M
- Amount sold: $9.2M
- Minimum investment: $50K
- Investors: 17
- Date of first sale: 2022-01-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-456463
Issuer
- Name: Advanced Nanotherapies Inc.
- CIK: 0001940022
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 10000 CEDAR AVE, CLEVELAND, OH, 44106
- Phone: 415-517-0867
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Marwan Berrada-Sounni | Director | Santa Clara, CA |
| Jerett Creed | Director | Cleveland, OH |
| Regina Groves | Director | Cleveland, OH |
| Mehdi Shishehbor | Director | Cleveland, OH |
| Phillippe Urbain | Director | Cleveland, OH |
| Marwan Berrada-Sounni | Executive Officer | Santa Clara, CA |
Other filings by this issuer (1)
More